Why should we consider methotrexate in future trials of steroid-resistant immune thrombocytopenic purpura? - Correspondence

•This letter highlights the possible mechanisms by which methotrexate would benefit patients with steroid-resistant immune thrombocytopenic purpura (SR-ITP).•This letter summarizes the published case reports in the literature about the use of methotrexate in patients with SR-ITP.•Accordingly, this l...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Immunology letters 2023-02, Vol.254, p.39-40
Hauptverfasser:	Abdelwahab, Omar Ahmed, Seif, Ali Mohamed, Sherif, Mohamed El-Sebaey
Format:	Artikel
Sprache:	eng
Schlagworte:	Humans ITP Methotrexate Purpura, Thrombocytopenic, Idiopathic Steroid-resistant immune thrombocytopenic purpura Steroids
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	•This letter highlights the possible mechanisms by which methotrexate would benefit patients with steroid-resistant immune thrombocytopenic purpura (SR-ITP).•This letter summarizes the published case reports in the literature about the use of methotrexate in patients with SR-ITP.•Accordingly, this letter highlights why we should consider methotrexate for future RCTs on patients with SR-ITP.
ISSN:	0165-2478 1879-0542
DOI:	10.1016/j.imlet.2023.01.008